. 2017 Apr 7;28(6):1260–1267. doi: 10.1093/annonc/mdx100
© The Author 2017. Published by Oxford University Press on behalf of the European Society for Medical Oncology.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
Figure 2.
Prevalence of ≥grade 2 CINV by cycle of chemotherapy.